Dr. Larry Ereshefsky to Present at BioXcel's Virtual KOL Event to Highlight BXCL501 as a Potential Treatment for Agitation

BioXcel Therapeutics, a clinical-stage biopharmaceutical company utilizing artificial intelligen...
Read More

Dr. Larry Ereshefsky Coauthors Article on Cost-Effectiveness of MDD Treatment, Vortioxetine

Larry Ereshefsky, Pharm.D., Chief Scientific Officer of Apex Innovative Sciences, has published ...
Read More

2021 Pharma Conference eCards from Apex Innovative Sciences

Our annual eCards are here and updated for 2021. Download the neuroscience-focused card as well ...
Read More